Search Within

Aliya Rose Ming Holland

Formats
  1. Meeting Abstract (10)
  2. Journal Article (8)
Groups
  1. Department of Medicine (18)
  2. Solid Tumor Oncology Division (18)
  3. Sloan Kettering Institute Postdocs (13)
  4. Melanoma and Immunotherapeutics Service (12)
  5. GSK Faculty (11)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Taha Merghoub (12)
  2. Jedd Wolchok (8)
  3. Dmitriy Zamarin (7)
  4. Levi Mark Mangarin (5)
  5. Sadna Budhu (5)
  6. Travis Hollmann (5)

More People

Years
  1. 2023 (1)
  2. 2022 (8)
  3. 2021 (4)
  4. 2020 (5)
Publications
  1. Gynecologic Oncology (3)
  2. Journal for ImmunoTherapy of Cancer (3)
  3. Journal of Clinical Oncology (3)
  4. Clinical Cancer Research (2)
  5. Cancer Research (1)
  6. Cancers (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (3)
  3. Biomed Central Ltd (3)
  4. Elsevier Inc. (3)
  5. American Society for Clinical Investigation (1)
  6. Cell Press (1)

More Publishers

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Study to evaluate intraperitoneal (IP) ONCOS-102 with systemic durvalumab in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Phase 2 results
    Meeting Abstract

    Zamarin, D.; Odunsi, K.; Zsiros, E.; Slomovitz, B. M.; Pimentel, A.; Duska, L. R.; Reilley, M.; Nemunaitis, J. J.; Hamouda, D. M.; Patel, H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase IB study of GITR agonist antibody TRX518 singly and in combination with gemcitabine, pembrolizumab, or nivolumab in patients with advanced solid tumors
    Journal Article

    Davar, D.; Zappasodi, R.; Wang, H.; Naik, G. S.; Sato, T.; Bauer, T.; Bajor, D.; Rixe, O.; Newman, W.; Qi, J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • In vivo phenotyping of the tumor-immune microenvironment in skin cancers
    Meeting Abstract

    Sahu, A.; Kraehenbuehl, L.; Holland, A.; Cordova, M.; Gill, M.; Alessi-Fox, C.; Gonzalez, S.; Kurtansky, N.; Rossi, A.; Marghoob, A.; more...
    Journal of Investigative Dermatology (2022)

    Fulltext@MSK | Save
  • In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response
    Journal Article

    Sahu, A.; Kose, K.; Kraehenbuehl, L.; Byers, C.; Holland, A.; Tembo, T.; Santella, A.; Alfonso, A.; Li, M.; Cordova, M.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Pilot trial of arginine deprivation plus nivolumab and ipilimumab in patients with metastatic uveal melanoma
    Journal Article

    Kraehenbuehl, L.; Holland, A.; Armstrong, E.; O'Shea, S.; Mangarin, L.; Chekalil, S.; Johnston, A.; Bomalaski, J. S.; Erinjeri, J. P.; Barker, C. A.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers
    Meeting Abstract

    Budhu, S.; Gupta, A.; Fitzgerald, K.; Giese, R.; Michel, A.; Holland, A.; Campesato, L. F.; Van Snick, J.; Uyttenhove, C.; Ritter, G.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save